Skip to main content
Embecta Corp. logo

Embecta Corp. - Investor Relations & Filings

Listed IPO Apr 2022
Ticker · EMBC ISIN · US29082K1051 LEI · 549300RPG8GXVDHNXZ62 US Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2022-01-11 Regulatory Filings
Country US United States of America
Listing US EMBC · 7 venues

Key figures FY2025

Period ended 2025-09-30 · USD
Headline annual figures for Embecta Corp., fiscal year 2025, reported in USD, with the source filing for each figure.
Total Revenues USD 1.08B per the Annual Report filed 2025-11-25
Net Income USD 95.40M per the Annual Report filed 2025-11-25
Total Assets USD 1.09B per the Annual Report filed 2025-11-25
Total Equity USD -650.60M per the Annual Report filed 2025-11-25
Cash from Ops USD 191.70M per the Annual Report filed 2025-11-25

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About Embecta Corp.

https://www.embecta.com/

Embecta Corp. is a global medical device company focused on improving the health and well-being of people living with diabetes. As one of the largest pure-play diabetes care companies, it leverages a nearly 100-year legacy in insulin delivery. The company's core business involves the manufacturing and distribution of insulin delivery devices, primarily pen needles and insulin syringes, which are used by over 30 million people in more than 100 countries. Embecta is also committed to providing educational resources and support on proper injection techniques to the global diabetes community.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings
2022-01-11 English
10-12B
Regulatory Filings Classification · 95% confidence The document is a Form 10 registration statement filed with the SEC, as indicated by the header 'FORM 10' and references to the Securities Exchange Act of 1934. It includes detailed information about the registrant, Embecta Corp., and incorporates by reference an information statement. The document is not an annual or quarterly report, earnings release, or other financial report but a registration statement for securities. Form 10 filings are regulatory filings used to register securities under the Exchange Act. Therefore, this document fits best under the category of Regulatory Filings (RNS). The document length is over 10,000 characters, indicating it is a full filing, not a brief announcement or certification.
2021-12-21 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from a company (Berra Newco, Inc.) to the SEC staff regarding comments on a draft registration statement on Form 10. It discusses amendments to the registration statement, responses to SEC comments on disclosures, financial statement notes, and other regulatory compliance matters. The document references a Form 10 registration statement, which is used for companies registering securities under the Securities Exchange Act of 1934, typically for becoming a public company. This is not an annual report, earnings release, or other financial report but rather a regulatory filing related to the registration process. The document is lengthy and substantive but is clearly a comment letter and amendment submission related to a registration statement, which falls under Regulatory Filings (RNS) as it does not fit other specific categories like Annual Report or Capital/Financing Update. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-09-03 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 10 registration statement filed confidentially with the SEC by Berra Newco, Inc. It is a regulatory filing related to the registration of securities under the Securities Exchange Act of 1934. The document includes cross-references to an information statement and various exhibits but does not itself contain financial statements or detailed financial analysis. It is a registration statement draft, not an annual report, earnings release, or other financial report. The document is over 10,000 characters and is a formal SEC filing. Given the nature of the document as a registration statement and the absence of substantive financial data or report content, it fits best under Regulatory Filings (RNS).
2021-09-03 English
Regulatory Filings 2021
Regulatory Filings
2021-08-12 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 10 registration statement filed confidentially with the SEC by Berra Newco, Inc. It is a registration document pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. The text includes references to various items typical of registration statements, such as business description, risk factors, financial information, executive compensation, legal proceedings, and exhibits. It is not an annual report, earnings release, or other financial report but a registration statement for securities. The document is not a report publication announcement or a certification but the actual registration filing. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and filings that do not fit other specific categories.
2021-07-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.